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Hyperelastosis Cutis (HC) is an autosomal recessive disorder in Quarter
Horses. Homozygous (Hr/Hr) horses are affected with fragile, hyperextensible
skin that sloughs and scars easily following minor trauma. Heterozygous (N/Hr)
horses appear normal, but carry one copy of the gene.

Objectives were to

determine inbreeding coefficients of affected (Hr/Hr), carrier (N/Hr), and normal
(N/N) Quarter Horses, compared to Thoroughbreds, and evaluate economic
effects of HC within the cutting horse industry. Of the top cutting horses from
1985 through 2006, 35 were confirmed carriers by either DNA analysis or
production of affected offspring. Although 23% of the earnings from the leading
100 lifetime earning sires ($388 million) were attributed to 12 carrier sires,
average offspring earnings of carrier sires were not significantly different from
normal sires. The increase in dollars is due to the number of earning offspring

produced by carriers, highlighting the need for DNA testing and appropriate
breeding selections.
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CHAPTER 1
INTRODUCTION

Significance
Hyperelastosis cutis (HC), also known as hereditary equine regional
dermal asthenia (HERDA), is an autosomal recessive skin disorder in Quarter
Horses (Rashmir et al., 2004, White et al., 2004, and Tryon et al., 2005).
Heterozygous (N/Hr) horses are carriers of the recessive Hr gene, but appear
normal, without physical signs of the disease.

Horses that are homozygous

recessive (Hr/Hr) are physically affected, and exhibit hyperextensible skin,
extensive cutaneous lesions, skin sloughing, and characteristic scarring.
Linebreeding, which is common in cutting horse bloodlines, can increase
homozygosity of recessive genes. There is no known treatment for the disease.

Thesis Statement and Objectives of the Study
The hypothesis for this study was that selection pressure for performance
traits associated with the Hr gene has resulted in higher inbreeding coefficients of
affected (Hr/Hr) and carrier (N/Hr) horses, and may have impacted earnings in
the cutting horse industry. The specific objectives of this study were to obtain
information about the level of inbreeding within distinct groups of Quarter Horses,
compared to Thoroughbreds as a control group, and evaluate the economic
1

effects of carrier (N/Hr) horses within the cutting horse industry compared to
normal (N/N) horses. Information about the numbers of carriers (N/Hr) and their
impact on the cutting horse industry is important in the development of breeding
strategies. Selective breeding could reduce the number of animals that suffer
from this disease and decrease financial losses incurred by owners.
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CHAPTER 2
LITERATURE REVIEW

Related Diseases
Hyperextensible, fragile skin is a feature of many inherited skin disorders
in animals and man. Ehlers-Danlos Syndrome (EDS) is the term used for the
human disease and is a group of diverse, inherited connective tissue disorders
that result from mutations in collagen genes. In other animals, including cattle,
sheep, dogs, cats, mink, and rabbit, the disease has been identified as
dermatosporaxis and cutaneous asthenia (Radostits et al, 2000 and Sequeira et
al., 1999). In horses, the disease is referred to as hyperelastosis cutis (HC) or
hereditary equine regional dermal asthenia (HERDA), (White et al., 2004).

Description and Diagnosis of the Disease
Hyperelastosis cutis in horses was first reported in 1978, (Lerner and
McCracken, 1978). Genetic studies based on the clinical diagnosis of the HC
phenotype in large numbers of progeny demonstrate that the skin disorder is
inherited as an autosomal recessive mutation. If a carrier (N/Hr) is bred to a
carrier (N/Hr), a 1:2:1 genetic ratio is observed with affected (Hr/Hr) male
progeny occurring at the same rate as affected (Hr/Hr) female progeny.

3

Recessive genes are generally expressed phenotypically when two copies
are inherited, one from the sire and one from the dam. The recessive Hr gene
must be homozygous (Hr/Hr) or present in duplicate to be physically apparent in
an affected horse. Carrier horses are heterozygous (N/Hr), with one copy of a
normal gene and one copy of the Hr gene. However, carriers (N/Hr) do not
appear to exhibit phenotypical manifestations of the disease, as the single
recessive gene remains silent.
Skin consists primarily of collagen. When collagen attaches with elastin,
the combination forms a strong connective material, which binds the skin layers
together. Normal collagen fibers are uniform and tightly packed.

However,

collagen fibers in an affected (Hr/Hr) horse are damaged and disorganized. This
weak connective material cannot stand up to external stress and the dermal
layers separate. Therefore, affected (Hr/Hr) horses have hyperextensible skin
that does not adhere properly to the body. Recently linkage analysis suggests
that the HC mutation is linked to ECA1 in a region containing PPIB genes.
These genes function in collagen metabolism (Tryon et al., 2007). However,
much information is yet to be learned about the development of the disease.
Initial clinical diagnosis of HC in an affected (Hr/Hr) horse is based on the
presentation of persistent lesions and characteristic scarring due to delayed,
impaired healing (Pascoe and Knottenbelt, 1999 and Stannard, 2000). Seromas
and hematomas, which are reported commonly, can be solitary or multiple and
are located predominantly on the dorsal body surface. The DNA test can be
used to confirm the clinical diagnosis and will identify the disease in pre-lesion
4

animals. The test utilizes hair or blood samples and detects affected (Hr/Hr),
carrier (N/Hr), and normal (N/N) status (Lee, 2008). DNA analysis is available at
Cornell University and the University of California at Davis.
An Equine Urinary Pyridinium Crosslink Assay screens for an elevated
ratio of deoxypyridinoline:pyridinoline, two byproducts of collagen degradation,
similar to human Ehlers-Danlos syndrome (Swiderski et al., 2006)

.

The urine

test is diagnostic in the presence or absence of the disease, but does not identify
the carrier (N/Hr) state.

Treatment and Prognosis of the Disease
No treatment exists except for minimization of environmental exposure
and trauma, coupled with diligent wound care. Since affected horses’ skin is
fragile, they generally cannot be ridden because of subsequent wounds caused
by the saddle. Due to the heritability of the disease, affected (Hr/Hr) horses are
generally not retained for breeding, and are frequently euthanized. Nevertheless,
the oldest affected (Hr/Hr) horse on record lived to an age of 17. Additionally
there is a wide variation in the expression of the disease, as each horse brings its
own unique genetic composition to bear on the expression of the disease.
Outside factors such as climate, diet, stress level, and sex also appear to
influence the severity of a horse’s condition.

5

Proliferation of the Disease
Affected (Hr/Hr) animals are most commonly produced by carrier (N/Hr-toN/Hr) matings.

Statistically, 25% of the offspring from such matings will be

homozygous (Hr/Hr) for the gene and will be affected with the skin defect; 50% of
all offspring will inherit one copy of the Hr gene and become carriers (N/Hr); and
25% will be normal (N/N) both genotypically and phenotypically. The expected
results of various breeding choices using Punnett squares are demonstrated in
Table 2.1.
Table 2.1 Genotype and Phenotype Comparisons.
GENOTYPES
BREEDING CHOICE
Carrier x
Carrier
Carrier x
Affected
Carrier x
Normal
Affected x
Affected
Affected x
Normal
Normal x
Normal

PHENOTYPES

Carrier
N/Hr

Affected
Hr/Hr

Normal
N/N

Normal
Appearance

Physically
Affected

50%

25%

25%

75%

25%

50%

50%

0%

50%

50%

50%

0%

50%

100%

0%

(N/Hr x
N/Hr)
(N/Hr x
Hr/Hr)
(N/Hr x
N/N)
(Hr/Hr x
Hr/Hr)
(Hr/Hr) x
N/N)

0%

100%

0%

0%

100%

100%

0%

0%

100%

0%

(N/N x N/N)

0%

0%

100%

100%

0%

Punnett Square Examples:
Carrier (N/Hr)
Carrier
(N/Hr)
N
Hr

N
N/N
Hr/N

Affected (Hr/Hr)
Carrier
(N/Hr)
N
Hr

Hr
N/Hr
Hr/Hr

Normal (N/N)
Carrier
(N/Hr)
N
Hr

N
N/N
Hr/N

Hr
N/Hr
Hr/Hr

Hr
N/Hr
Hr/Hr

Normal (N/N)
Affected
(Hr/Hr)
Hr
Hr

N
N/N
Hr/N
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N
Hr/N
Hr/N

N
Hr/N
Hr/N

For example:
•

When a carrier (N/Hr) is bred to an affected (Hr/Hr) horse, half of
the foals will be carriers (N/Hr) genotypically, although normal in
appearance and half will be affected (Hr/Hr), both genotypically
and phenotypically.

•

When a carrier (N/Hr) is bred to a normal (N/N) horse, half of the
offspring will be normal (N/N) genotypically and phenotypically,
and half will be carriers (N/Hr) genotypically, but appear normal
phenotypically.

•

When an affected (Hr/Hr) horse is bred to another affected (Hr/Hr)
horse, all of the offspring will be affected (Hr/Hr), since a
homozygous animal can produce only one gene combination.

•

When an affected (Hr/Hr) horse is bred to a normal (N/N) horse,
none will be physically affected (Hr/Hr), but all of the offspring will
be carriers (N/Hr) by genotype, although normal by phenotype.

As with any recessive trait, in any species, removing the carrier state
from the population is difficult.

Pedigree Evaluations and Confirmation of an Autosomal Recessive Mode
of Inheritance
The pedigrees of the affected (Hr/Hr) horses seen at MSU implicated a
famous cutting horse bloodline, when a common link to Poco Bueno became
apparent during pedigree searches. The evaluation of 75 pedigrees indicated
that 96% trace back to Poco Bueno bloodlines within 6 generations and 4% trace
back to Poco Bueno within the 7th generation; this study also confirmed an
autosomal recessive mode of inheritance. (Rashmir et al., 2004).
In 2005, a study based on 58 affected HERDA horses assessed the
heritability and mode of inheritance of the disease.

(Tryon et al., 2005).

Heritability was estimated to be 0.38 ± 0.13, which is consistent with a heritable
7

locus.

The study excluded an X-linked mode of inheritance for the disease,

indicating that sex does not play a role in the heritability of the disease. Full
pedigrees were available for 52 of 58 affected horses. Analyses revealed that all
52 affected horses were related to the same undisclosed stallion on both
maternal and paternal sides of the pedigree, consistent with a single Mendelian
autosomal recessive mode of inheritance. (Tryon et al., 2005).

Use of Linebreeding/Inbreeding Mating Strategies
Inbreeding is defined as the mating of individuals more closely related
than the average for the population, or that results in the sire and the dam having
common ancestors. (Bourdon, 2000). If parents are completely unrelated, there
is no inbreeding, which is unlikely among animals of the same breed. Therefore,
for practical purposes in this study, if two mated individuals had no common
ancestor within the last five generations, their progeny were not considered
inbred (Vogt et al., 2005).
The primary consequence of inbreeding is an increase in homozygosity,
the probability that both genes of a pair are identical by descent (copies of a
single ancestral gene). Within a breed, some proportion of all the genes will be
homozygous. The inbreeding coefficient may be regarded as indicating what
proportion of the remaining genes has been made homozygous by inbreeding.
Calculation of inbreeding coefficients is an attempt to measure the probable
percentage reduction in heterozygosity (increase in homozygosity), relative to a
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base population. However, it is not a direct measure of homozygosity because
the two alleles may be alike for other reasons.
Mean inbreeding coefficient for 52 affected horses with full pedigrees was
0.0261; four fold higher than the mean of 0.0066 for control horses (Tryon et al.,
2005).

Thirty of these horses had inbreeding loops that led to a calculated

inbreeding coefficient greater than zero, ranging from 0.25 to 0.008. However,
these numbers are representative of a subset of the population, as Quarter
Horses represent a diverse breed, and selection has been used to produce
numerous performance disciplines, such as cutting, reining, halter, pleasure
events, and racing. Many of the assumptions associated with genetic analysis,
such as random mating of an outbred population and Hardy-Weinberg
Equilibrium, cannot be relied on when determining the genetic basis of the
disease or easily extrapolated to the entire population. Additionally, stallions that
have sired thousands of foals contribute disproportionately to the gamete pool,
which can alter the gene frequency over time (Tryon et al., 2005).
Poco Bueno’s genetic contribution has been multiplied through many
generations, so the opportunity for carrier (N/Hr-to-N/Hr) matings has increased.
Poco Bueno sired 405 AQHA registered first generation foals, 50% of which
should be carriers (N/Hr). His second generation included 537 foals, 25% of
which should be carriers (N/Hr), and his third generation included 1,352 foals,
12.5% of which should be carriers (N/Hr). These three generations alone total
approximately 500 carriers (N/Hr) from Poco Bueno. According to AQHA, of the
3.2 million registered Quarter Horses that are still alive, 1.7 million trace back to
9

Poco Bueno, which is considered the fastest growing segment of the Quarter
Horse population (Winand, 2008, personal communications).

Similarities to HYPP
An autosomal codominant disease in Quarter Horses, known as
Hyperkalemic Periodic Paralysis (HYPP), causes uncontrolled muscle twitching
and profound muscle weakness. HYPP is inherited as a codominant trait, which
means a heterozygous (N/H) or affected stallion or mare bred to a homozygous
(N/N) normal horse, will result in approximately half of the offspring being
affected and half being normal.
Along with superior muscling desired by halter horse breeders, the sire
Impressive was also the source of the gene for this disease. A genetic defect
disrupts the sodium ion channel and results in an excessive amount of potassium
in the blood, causing the muscles to contract more readily, potentially resulting in
paralysis, cardiac arrest, or respiratory failure.

However, in contrast to HC,

HYPP is treatable through diet and medication in many cases.
HYPP

is

listed

as

a

genetic

defect

Recommendations for DNA testing began in 1998.

in

AQHA's

regulations.

Foals of 2007 and later

tracing to Impressive are required to be parentage verified and tested for HYPP,
unless their Impressive-bred parent already has N/N results on file. Foals testing
homozygous (H/H) for HYPP are no longer eligible for AQHA registration (2007
55th edition of the Official Handbook of AQHA’s rule and regulations).
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CHAPTER 3
MATERIALS AND METHODS

Phase I - Epidemiology
Identification of Carrier (N/Hr) and Affected (Hr/Hr) Horses
Carrier status (N/Hr) for the disease was determined by either DNA
analysis or production of an affected (Hr/Hr) offspring by a phenotypically normal
sire or a dam. Due to the autosomal recessive nature of the disease, production
of an affected (Hr/Hr) offspring confirms that both sire and dam are carriers
(N/Hr).
Selection of Groups
The top money winners and lifetime earning sires were evaluated to
determine which carry the Hr gene. The inbreeding coefficients and relationship
coefficients were calculated for four distinct groups of horses to address and
compare differences in inbreeding levels between the groups, including:
•

five randomly-selected DNA-confirmed (Hr/Hr) horses that were
identified in this study as affected with the disease and known to be
bred from cutting horse lines,

•

the top 5 five-year leading cutting horse sires for years 2001
through 2005 that were DNA-confirmed carrier (N/Hr) horses,

11

•

the top 5 five-year leading cutting horse sires for years 2001
through 2005 that were DNA confirmed or mathematically
confirmed normal (N/N) horses, and

•

the top 5 earning Thoroughbreds for years 2001 through 2005.
HC status of animals was confirmed by DNA analysis (patent

pending) by Dr. Nena Winand at Cornell University’s College of Veterinary
Medicine Molecular Genetics Laboratory. In the absence of a DNA test, the
normal (N/N) status of an animal was determined mathematically by examining
the status of the progeny resulting from at risk matings using the AQHA
database. Normal (N/N) status was considered to be confirmed when 100 or
more matings to at risk pedigrees failed to produce an affected (Hr/Hr) individual.
If the carrier status (N/Hr) rate among at risk pedigrees approaches 20%, lack of
an affected (Hr/Hr) offspring following 100 matings to at risk pedigrees assures
with greater than 99% accuracy that the animal in question lacks the Hr allele
(Bourdon, 2000). The carrier status (N/Hr) rate among horses tested to date is
28% (Bannasch, 2008).
Calculation of Inbreeding Coefficients
SAS PROC INBREED was selected as the statistical software to calculate
the inbreeding coefficients of the selected individuals within the four selected
groups. The coefficient of relationship between individuals was also calculated in
a covariance coefficient matrix.

For individual X, the INBREEDING

COEFFICIENT, which indicates the probability that the two alleles for any gene
are identical by descent, is denoted by Fx and is equal to the coancestry between
12

its parents, or Fx = fAB. The covariance coefficient between individuals X and Y,
or COEFFICIENT OF RELATIONSHIP, is defined by Cov(X,Y) = 2fXY, where fXY
is the coancestry between X and Y. (Falconer and Mackay, 1996 and SAS,
2004). Only a full DNA analysis can identify exactly how inbred these horses
are; however, inbreeding probabilities or coefficients estimated through pedigree
analyses can be used to predict the probable percentage of identical genes that
were inherited as a function of the number and location of the common ancestors
in the pedigree.
A five-generation pedigree of each horse (n=5), within each of the four
groups, was formatted in a spreadsheet for using SAS PROC INBREED to
calculate the inbreeding coefficient of each horse within each group.
Coancestors (parents appearing on both the sire and the dam side of the
pedigree) were identified and utilized in the computation of the individual’s
inbreeding coefficients.

(SAS/Genetics® version 9.1 statistical software, SAS

Institute Inc., Cary, NC).
Mean inbreeding coefficients within each group were assessed to
determine if they were significantly different from zero (non-inbred) using the
Student’s t-test.

A One-Way Analysis of Variance (ANOVA) with a Tukey’s

Studentized Range (HSD) Test was used to compare mean inbreeding
coefficients among groups, where the independent variable was the group
affected (Hr/Hr), carrier (N/Hr), and normal (N/N) Quarter Horse, or
Thoroughbred) and the dependent variable was the mean inbreeding coefficient.
Values were considered significant at P ≤ 0.05. Means and descriptive statistics
13

were also calculated for each group using SAS® Enterprise© Guide 4.1 statistical
software, (SAS Institute Inc., Cary, NC).

Phase II - Economics
Performance records for all ages and all divisions were obtained for the
top 100 horses and top 100 lifetime earning (LTE) sires within the cutting horse
industry for years 1985 through 2006, (EquiStat, 1986 – 2007), and are included
in Appendix A. Economic data were obtained from Quarter Horse News and
Equi-Stat, as well as the American Quarter Horse Association.

Top cutting

horses, reining horses, and reining cow horses were compared to the list of
confirmed carrier (N/Hr) and affected (Hr/Hr) horses that was previously
assembled.

Carriers (N/Hr) were identified in several of the performance

disciplines. However, due to the prevalence of the disease within the top cutting
sires, this evaluation focused on the cutting horse industry only.
Annual Trends
Data were collected and analyzed for annual trends for top horses of all
ages and all divisions, including:
•

annual horses’ winnings, all horses (stallions, geldings, and
mares), all ages, all divisions, no information on offspring;

•

leading sires’ earnings, all ages, all divisions, including total
offspring and average offspring earnings for each of the top
sires in a given year; and

•

leading lifetime earnings (LTE) of sires, all ages, all
divisions, including total offspring earnings and average
offspring earnings over each top sire’s lifetime through 2006.
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A linear model using a GLM Procedure (SAS® Enterprise© Guide 4.1 statistical
software, SAS Institute Inc., Cary, NC) was used to identify significant differences
at P ≤ 0.05, where the dependent variable was averaged annual dollars of
offspring earnings and the classification variables were year and Hr group.
Offspring Information
A One-Way Analysis of Variance (ANOVA), with a Tukey’s Studentized
Range (HSD) Test was used to compare the offspring numbers of carrier (N/Hr)
sires to normal (N/N) sires for the leading 100 lifetime earning sires as of 2006,
(SAS® Enterprise© Guide 4.1 statistical software, SAS Institute Inc., Cary, NC). In
the first analysis, the dependent variables were the number of earning,
performing, or total offspring and the independent variable was Hr group. In a
different analysis, the dependent variable was average offspring earnings and
the independent variable was Hr group. Values were considered significant at P
≤ 0.05. Analysis of variance was additionally used to compare offspring and
average earnings within the following groups:
•

Top Five Carrier (N/Hr) sires to Top Five Normal (N/N) sires

•

Top Ten Carrier (N/Hr) sires to Top Ten Normal (N/N) sires

•

Top 25 Carrier (N/Hr) horses to Top 25 Normal (N/N) horses

•

Top 50 Carrier (N/Hr) horses to Top 50 Normal (N/N) horses

•

Top 12 Carrier (N/Hr) horses to Top 12 Normal (N/N) horses

•

Top 12 Carrier (N/Hr) horses to Top 25 Normal (N/N) horses

•

Top 12 Carrier (N/Hr) horses to Top 50 Normal (N/N) horses
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Top 250 Five-Year Sires
Offspring earnings of the top five leading carrier (N/Hr) sires (DNA
confirmed) were compared to that of the top five leading normal (N/N) sires (DNA
or mathematically confirmed) for the five-year period from 2001 through 2005.
The average offspring earnings per sire was calculated as the total earnings of all
the sire’s offspring during the five-year period divided by the number of offspring
earning money during the period. A One-Way Analysis of Variance (ANOVA)
with a Tukey’s Studentized Range (HSD) Test was used to compare the mean
values for each group of sires (carrier N/Hr vs. normal N/N), where the
dependent variable was the average offspring earnings and the independent
variable was the group, (SAS® Enterprise© Guide 4.1 Statistical Software, SAS
Institute Inc., Cary, NC). Average offspring earnings were also correlated to
inbreeding coefficients for the top five carriers (N/Hr) and top five normal (N/N)
horses using a linear regression, with the inbreeding coefficient as the
independent variable.
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CHAPTER 4
RESULTS

Phase I - Epidemiology
Identification of Carrier (N/Hr) and Affected (Hr/Hr) Horses
A total 194 affected (Hr/Hr) horses were identified through DNA analysis
and urine testing, or clinical presentation, 99 of which were mares and 63 of
which were stallions, (Table 4.1). As an affected (Hr/Hr) horse was identified,
pedigrees were obtained to determine the sire and dam, and thus establish them
as carriers (N/Hr). Additionally, 283 offspring of known affected (Hr/Hr) horses
carry at least one copy of the Hr gene. From this information, carrier (N/Hr)
status was determined for 606 horses, 265 of which were mares and 285 of
which were stallions.
Table 4.1

Horses Identified in Phase I by Sex and Status.

STATUS

Total

Geldings

Mares

Stallions

Unknown

Affected (Hr/Hr)

194

22

99

63

10

Carrier (NHr)

606

56

265

285

0

800

78

364

348

10

Total
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As shown in Table 4.2, 2.1% of the total 1,634 horses identified in the
annual top horses and leading sires for years 1985 through 2006, carry the Hr
gene. Eight percent of the top 250 five-year sires for years 2001 through 2005
are carriers (N/Hr). Twelve percent of the top 100 leading lifetime earning (LTE)
sires are carriers (N/Hr), as well as two percent of the dams in the top 100 LTE
dams. Ten of the 35 carrier (N/Hr) horses were a top performer and producer, or
in other words, 29% were both a superior horse and an outstanding sire.
However, 12 of the 35 carrier (N/Hr) horses (or 34%) were top producers of great
offspring, but have not been a top performer themselves.
Table 4.2

Summary of Performance Records from 1985 through 2006,
indicating Horses identified as Carriers (N/Hr) vs. Normal (N/N).

Category
Summary
Total
Performance
Horses 19852006

Total
Horses

Carrier
Horses

% Carriers

Normal
Horses

% Normal
Horses

1,634

35

2.1%

1,599

97.9%

Top 5-Year
Sires
2001-2005

250

20

8.0%

230

92.0%

Leading Sires
2006

100

12

12.0%

88

88.0%

Leading
Dams
2006

100

2

2.0%

98

98.0%
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Comparison of Inbreeding Coefficients to Zero (Non-Inbred)
When horses have no common ancestors (no inbreeding), the inbreeding
coefficient is zero. The mean inbreeding coefficients were calculated for groups
of affected (Hr/Hr), carrier (N/Hr), and normal (N/N) Quarter Horses, and
Thoroughbreds, as a control group. Table 4.3 displays the mean inbreeding
coefficients for each group of five horses studied.
Table 4.3

Mean Inbreeding Coefficients for Each Group of Horses (n=5).
Mean
Inbreeding
Coefficient

Std Error
(SEM)

Std Dev

Student's t

P-Value

AFFECTED (Hr/Hr)

0.0514

0.0113

0.0252

4.5536

0.0104

CARRIER (N/Hr)

0.0238*

0.0102

0.0229

2.3278

0.0804

NORMAL (N/N)

0.0024*

0.0016

0.0037

1.4804

0.2129

GROUP

0.0102
0.0035
0.0077
2.9398
0.0424
Within a column, means without * (a common superscript letter) differ (P < 0.05).
THOROUGHBRED

The mean inbreeding coefficient of horses in the affected (Hr/Hr) group
was 0.0514, indicating they were significantly more inbred than non-inbred
animals (t = 4.5536, P = 0.0104). The mean inbreeding coefficient for the carrier
group (N/Hr) was 0.0238, which trended toward being significantly different from
that of non-inbred horses (t = 2.3278, P = 0.0804). The inbreeding coefficient of
horses in the normal (N/N) group was 0.0024, indicating that they were not
significantly more inbred than non-inbred horses (t = 1.4804, P = 0.2129). Within
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the four groups of horses studied, normal (N/N) horses were the least inbred and
had the least variation in inbreeding coefficients among the groups. The group of
Thoroughbreds had an inbreeding coefficient of 0.0102, which was significantly
inbred compared to non-inbred animals (t = 2.9398, P = 0.0424).
Comparison of Inbreeding Coefficients among Groups
Inbreeding coefficients among the four groups are shown in Figure 4.1
and Table 4.4 (F = 7.50, P = 0.0024). Means with the same letter in Table 4.4
are not significantly different.

8.0%
7.0%
6.0%
Affected* 0.0514

5.0%
4.0%
3.0%
Carrier 0.0238

2.0%

Thoroughbred*
0.0102

1.0%
Normal 0.0024

0.0%
*Significantly different from zero (non-inbred) at P ≤ 0.05.
Figure 4.1

Comparison of Mean Inbreeding Coefficients (y-axis) among Four
Groups of Horses (x-axis), with Standard Error Bars.
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Table 4.4

ANOVA Model and Comparison of Mean Inbreeding Coefficients
among Four Groups of Horses (n=5).

Source

DF

Sum of
Squares

Model

3

0.0069

0.0023

Error
Corrected
Total

16

0.0049

0.0003

19

0.0119

Mean Square F value
7.50

Mean
Inbreeding
Coefficient for
group

Std Error

AFFECTED (Hr/Hr)

0.0514

0.0113

A

CARRIER (N/Hr)

0.0102
0.0016

A

NORMAL (N/N)

0.0238
0.0024

THOROUGHBRED

0.0102

0.0035

STATUS

Pr>F
0.0024

Tukey’s
Grouping*

B
B
B

*Means with the same letter are not significantly different at Alpha
0.05.
Horses in the affected (Hr/Hr) group were significantly more inbred than
the horses in the groups of normal (N/N) horses and Thoroughbreds. The group
of affected (Hr/Hr) horses was twice as inbred as the group of carriers (N/Hr);
however, there was no significant between these two groups. Carriers (N/Hr)
were ten times more inbred than normal (N/N) horses and twice as inbred as
Thoroughbreds; however, the differences were not statistically significant. The
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groups of normal (N/N) horses and Thoroughbreds were not significantly different
from each other or from the group of carriers (N/Hr), but these two groups were
significantly less inbred than the group of affected (Hr/Hr) horses. Although, the
group of carriers (N/Hr) was not significantly different than any of the other three
groups of horses, the inbreeding coefficient for carriers (N/Hr) was intermediate
between the affected (Hr/Hr) horses and the normal (N/N) Quarter Horses and
Thoroughbreds.

Phase II - Economics
A total 1,634 horses were identified in the published lists of the top money
winning horses and leading lifetime earning sires from 1985 through 2006. As
presented previously in Table 4.2, 35 of these horses were confirmed carriers
(N/Hr), with 20 in the top 250 five-year sires for years 2001 through 2005, 12 in
the leading lifetime earning (LTE) sires, and two in the top 100 lifetime earning
dams.
Trends – Annual Winnings of Top Horses
Total annual winnings of carriers (N/Hr) and normal (N/N) horses were
divided by the number of horses in each group to depict the averaged annual
winnings for each group from 1990 through 2005, illustrated in Figure 4.2.
Carrier (N/Hr) winnings increased an average of $4,575 per year and normal
(N/N) horses increased an average of $2,112 per year.

The differences in

averaged annual winnings between carriers (N/Hr) and normal (N/N) horses and
between years were statistically significant (F = 131.67, P < 0.0001, Table 4.5).
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The greater increases in carrier (N/Hr) winnings compared to normal (N/N) horse
winnings are most likely due to a greater number of earning offspring for carrier
(N/Hr) sires compared to normal (N/N) sires.

With carrier (N/Hr) winnings

increasing at twice the rate of normal (N/N) horses, carriers (N/Hr) exceeded
normal (N/N) horses as of 2001.
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Carrier (N/Hr) Average
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Normal (N/N) Average

$140,000

Linear (Carrier (N/Hr) Average)
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Linear (Normal (N/N) Average)
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y = $4,575x + $14,298
$80,000

y = $2,112x + $42,482
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Figure 4.2
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Averaged Annual Winnings for Carrier (N/Hr) and Normal (N/N)
Horses for 1990 through 2005 including Stallions, Geldings, and
Mares, (No Offspring Information).
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Table 4.5

ANOVA GLM Procedure Model for Averaged Annual Winnings per
Group of Horse per Year.

Source

DF

Sum of Squares

Mean Square

Model
Error

1
31

103,275,072,784 103,275,072,784
24,314,456,986
784,337,322

Corrected
Total

32

127,589,529,770

F value

Pr>F

131.67

<0.0001

Trends – Annual Earnings of Leading Sires
A similar evaluation was conducted for leading sires from 1991 through
2006.

Total annual earnings of carrier (N/Hr) and normal (N/N) sires were

divided by the number of sires in each group. The averaged annual earnings for
carrier (N/Hr) and normal (N/N) sires are illustrated in Figure 4.3. Carrier (N/Hr)
sire earnings increased by an average of $63,207 per year compared to normal
(N/N) sire earnings, which increased by an average of $24,525 per year. The
differences between the two groups and between years were statistically
significant (F = 165.25, P < 0.0001, Table 4.6). Again, earnings of carriers (N/Hr)
increased more than 61% per year than normal (N/N) sires.
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Figure 4.3

Averaged Annual Earnings of Carrier (N/Hr) and Normal (N/N)
Sires for Years 1991 through 2006.

Table 4.6

ANOVA GLM Procedure Model for Comparing Average Offspring
Earnings of Leading Annual Sires per Year.

Source

DF

Sum of Squares

Mean Square

F value

Pr>F

Model
Error

1
35

1.5185855E13
3.2164441E12

1.5185855E13
91,898,403,145

165.25

<0.0001

Corrected
Total

36

1.8402299E13

Trends – Lifetime Earnings of Leading Sires
Total lifetime earnings (LTE) of the top 100 leading sires also were
reported annually and included offspring earnings over the sire’s lifetime. The
total earnings of carrier (N/Hr) and normal (N/N) sires were divided by the
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number of sires in each group to depict the averaged earnings per group from
1998 through 2006, illustrated in Figure 4.4. Although carrier (N/Hr) sires earned
more money than normal (N/N) sires on average per year, their increase of
$182,277 average per year was slightly less than the average increase of
$187,532 per year for normal (N/N) sires.

The difference between the two

groups and between years were statistically significant (F = 83.27, P < 0.0001,
Table 4.7).
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Figure 4.4

Normal
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Average

Averaged Total Lifetime Earnings of Offspring per Sire for Leading
Lifetime Earning Carrier (N/Hr) and Normal (N/N) Sires.
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Table 4.7

ANOVA GLM Procedure Model for Comparing Average Offspring
Earnings of Lifetime Earning Carrier (N/Hr) and Normal (N/N) Sires
per Year.

Source

DF

Sum of Squares

Mean Square

F value

Pr>F

Model

1

3.858546E14

3.858546E14

83.27

<0.0001

Error

17

7.8773874E13

4.6337573E12

Corrected
Total

18

4.6462848E14

Figure 4.5 displays the percentage of carrier (N/Hr) earnings relative to the
total earnings of both carrier (N/Hr) and normal (N/N) sires from 1998 through
2006.

Earnings of carriers (N/Hr) increased an average of one-half percent
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Total 100 Sire Lifetime Earnings (1998 through 2006).
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As of 2006, earnings of the leading 100 lifetime earning sires were $388
million, of which 22.7% ($88 million) was attributed to 12% of the sires, which
have been DNA confirmed as carriers (N/Hr).
Offspring Information
As of 2006, 30% of the progeny produced by carriers (N/Hr) were earning
offspring, whereas 25% of the progeny produced by normal (N/N) sires were
earning offspring (Table 4.8).

In addition, 40% of the offspring produced by

carriers (N/Hr) have performed, while only 36% of the offspring produced by
normal (N/N) sires have performed.
Table 4.8

Comparison of the Leading 100 Lifetime Earning Carrier (N/Hr) and
Normal (N/N) Sires’ Offspring Information including Average
Earnings per Offspring and Numbers of Offspring (2006).
Average
Offspring
Earnings/
2007 SR

TOTAL OFFSPRING
EARNINGS

$19,165
$18,472

Carriers (N/Hr) n=12
Normal (N/N) n=88
Total

Total Number
of Earning
Offspring/
2007 SR

3,666
15,683
19,349
Total Number
of Performing
Offspring/
AQHA*

TOTAL OFFSPRING
EARNINGS
Carriers (N/Hr) n=12
Normal (N/N) n=88
Total

4,815
22,387
27,202

Average
Number of
Earning
Offspring/
2007 SR

306
178
193
Average
Number of
Performing
Offspring/
AQHA*

401
257
275

Average %
Earning
Offspring/
Total
Offspring

30%
25%
Average %
Performing
Offspring/
Total
Offspring

40%
36%

Total Number
of Total
Offspring/
AQHA*

11,168
57,850
69,018
Average
Number of
Total
Offspring/
AQHA*

931
665
697

*Based on 99 horses

There was a significant difference in the number of earning offspring
produced by carriers (N/Hr) compared to the number of earning offspring
produced by normal (N/N) sires (F = 4.21, P = 0.0428). However, there was no
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significant difference in the number of performing (F = 3.62, P = 0.0600) or total
offspring (F = 3.46, P = 0.0658) between the two groups, Figure 4.6.
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A
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B
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A
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A
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TOTAL
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100.00
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400.00

Mean Number of
Noncarrier Total
Offspring (n=87)

200.00

Tukeys
Std Error Grouping*

Tukeys
Std Error Grouping*

0.00

TOTAL

*Means with the same letter in the Tukey’s Grouping are not significantly different
at an Alpha 0.05.
Figure 4.6

Comparisons of Number of Earning, Performing, and Total
Offspring of Carrier (N/Hr) and Normal (N/N) Sires as of 2006.

For comparison purposes, the same analyses were conducted on various
combinations of leading sires and the number of offspring produced by carriers
(N/Hr) vs. normal (N/N) sires. In each of the following cases, there was no
significant difference in any of the number of offspring between the groups at a P
≤ 0.05, not even in the number of earning offspring between the groups.
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•

Top Five Carrier (N/Hr) sires to Top Five Normal (N/N) sires

•

Top Ten Carrier (N/Hr) sires to Top Ten Normal (N/N) sires

•

Top 25 Carrier (N/Hr) horses to Top 25 Normal (N/N) horses

•

Top 50 Carrier (N/Hr) horses to Top 50 Normal (N/N) horses

•

Top 12 Carrier (N/Hr) horses to Top 12 Normal (N/N) horses

•

Top 12 Carrier (N/Hr) horses to Top 25 Normal (N/N) horses

•

Top 12 Carrier (N/Hr) horses to Top 50 Normal (N/N) horses

Average offspring earnings of the leading 100 lifetime earning sires as of
2006 averaged $19,165 for carrier (N/Hr) sires (n=12), which was greater than
the average of $18,472 for normal (N/N) sires (n=88), illustrated in Figure 4.7.
However, there was no significant difference between the two groups (F = 0.08,
P = 0.7801, Table 4.9).

$25,000
$20,000

$19,165 $18,472

$15,000
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(n=88)
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Figure 4.7

Carrier
(N/Hr)
Mean
Offspring
Earnings
(n=12)

1

Comparison of Average Offspring Earnings of the Leading 100
Lifetime Earning Carrier (N/Hr) Sires and Normal (N/N) Sires as of
2006.
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Table 4.9

ANOVA Model and Comparison of Average Offspring Earnings of
the Leading 100 Lifetime Earning Carrier (N/Hr) Sires and Normal
(N/N) Sires as of 2006.

Source

DF

Sum of Squares

Model
Error

1
98

5076753
6344972278

Corrected
Total

99

6350049031

STATUS
CARRIER (N/Hr)
NORMAL (N/N)

n=

Mean Square

F value

5076753
64744615

Mean Dollars
$ of Earning
Offspring

0.08

Standard
Error

Pr>F
0.7801

Tukeys
Grouping*

12
$19,165
$2,423 A
88
$18,472
$853 A
100
$18,555
$801
*Means with the same letter are not significantly different at an Alpha 0.05.

Top 250 Five-Year Sires
Average offspring earnings of the top five carrier (N/Hr) sires (n=5) for the
five-year period of 2001 through 2005, averaged $17,044, which was less than
the average of $18,887 for normal (N/N) sires (n=5), illustrated in Figure 4.8.
However, there was no significant difference between the two groups (F = 0.18,
P = 0.6858), Table 4.10
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Figure 4.8

Comparison of Average Offspring Earnings of the Top Five-Year
Carrier (N/Hr) Sires and Normal (N/N) Sires (2001 through 2005).

Table 4.10

ANOVA Model and Comparison of Average Offspring Earnings of
the Top Five-Year Carrier (N/Hr) Sires and Normal (N/N) Sires
(2001 through 2005).

Source

DF

Sum of Squares

Model
Error

1
8

8484252.1
385448358.4

Corrected
Total

9

393932610.5

Mean Square

F value

8484252.1
48181044.8

Mean
Offspring
Earnings $

Pr>F

0.018

STATUS

n=

CARRIER (N/HR)

5

$17,044

$3,854 A

NORMAL (N/N)

5

$18,887

$2,102 A

Std Error

0.6858

Tukey’s
Grouping*

10
$17,965
$2,092
*Means with the same letter are not significantly different at an Alpha 0.05.
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Comparison of Inbreeding Coefficients and Offspring Earnings
Inbreeding coefficients and average offspring earnings of the top five
carriers (N/Hr) and top five normal (N/N) sires for 2001 through 2005 are
compared in Figure 4.9.
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Figure 4.9

Comparison of Mean Inbreeding Coefficients of Top Five-Year
Carrier (N/Hr) Sires and Normal (N/N) Sires and Comparison of
Average Offspring Earnings of Top Five-Year Carrier (N/Hr) Sires
and Normal (N/N) Sires (n=5).

Carriers (N/Hr) had a mean inbreeding coefficient of 0.0238, which was
ten times greater than the inbreeding coefficient for normal (N/N) sires of 0.0024.
Average offspring earnings of carrier (N/Hr) sires were $17,044 and average
offspring earnings of normal (N/N) sires were $18,887.

Neither inbreeding

coefficients (Table 4.4) nor average offspring earnings (Table 4.10) were different
between carriers (N/Hr) and normal (N/N) sires.

Figure 4.10 displays the

correlation of the effect of inbreeding coefficients on average offspring earnings
of carrier (N/Hr) vs. normal (N/N) sires. A correlation value (r) for the relationship
of inbreeding coefficients and average offspring earnings was 0.0070 for normal
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(N/N) sires, indicating that there was almost no correlation between inbreeding
coefficients and average offspring earnings of normal (N/N) horses. However,
there was a positive correlation value between the two parameters for carrier
(N/Hr) sires, which was 0.6578, indicating that as the level of inbreeding
increases, the average offspring earnings increase.
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Figure 4.10 Correlation of Top Carriers (n=5) and Top Noncarriers (n=5)
Inbreeding Coefficients vs. Average Offspring Earnings.
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However, when the one outlier horse (a pre-eminent sire) for carriers
(N/Hr) was removed in Figure 4.11, a correlation value of 0.4925 was calculated,
indicating that as the level of inbreeding increases, the average offspring
earnings decrease.
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Figure 4.11 Correlation of Top Carriers (n=4 without outlier) and Top
Noncarriers (n=5) Inbreeding Coefficients vs. Average Offspring
Earnings.

A summary of the results presented in the tables and figures is provided in
Appendix B.
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CHAPTER 5
DISCUSSION

Phase I - Epidemiology
Linebreeding/inbreeding programs are used to maintain a degree of
genetic relationship to an outstanding ancestor.

Although animals with

performance advantages can be produced, increased inbreeding can result in a
higher frequency of hereditary abnormalities, such as HC in Quarter Horses, and
eventually an overall reduction in performance due to inbreeding depression.
Compared to a non-inbred animal (zero inbreeding), the normal (N/N)
horses in the group studied also were not inbred.

In addition, normal (N/N)

horses had the lowest inbreeding coefficient of the four groups. Although carriers
(N/Hr) had an inbreeding coefficient of 2% and demonstrated a trend toward
inbreeding, this was not statistically significant.

The inbreeding coefficient of

carrier (N/Hr) horses was considerably higher than normal (N/N) Quarter Horses
and Thoroughbreds, although it was not statistically different from the inbreeding
coefficient of any of the other groups.

Affected Quarter Horses and

Thoroughbreds were significantly inbred, with the group of affected (Hr/Hr)
Quarter Horses being the most inbred of the groups studied. Affected (Hr/Hr)
horses, which manifest the disease physically, were twice as inbred as carriers
(N/Hr), 21 times more inbred than normal (N/N) horses, and five times more
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inbred than Thoroughbreds, further demonstrating the negative effects of
inbreeding. This finding is consistent with an increase in inbreeding levels and
an increase in hereditary abnormalities due to increased homozygosity of harmful
recessive alleles. Despite the harmful effects, inbreeding has been useful in the
development of prepotent animals that uniformly stamp desirable characteristics
upon their offspring by replicating genes for good conformation, athleticism, and
attitude. However, it also exposes certain weaknesses within a breed such as
HC.
Quarter Horses represent a diverse breed, and selection has been used to
produce numerous performance disciplines, such as cutting, reining, halter,
pleasure events, and racing. The inbreeding coefficients calculated for this study
were representative of extremely small groups (n=5) of affected (Hr/Hr), carrier
(N/Hr), and normal (N/N) Quarter Horses within the cutting industry and may not
reflect true inbreeding levels. The same would be true for the Thoroughbred
population, as the five Thoroughbreds chosen for the study were the top five
money winners for the period 2001 through 2005. However, the relatively high
inbreeding coefficient for this group of Thoroughbreds compared to normal (N/N)
Quarter Horses in this study does indicate that elite Thoroughbreds are more
inbred than the elite normal (N/N) Quarter Horses. This finding is not surprising
in light of the closed studbook and the tremendous selection pressure within the
Thoroughbred population. When a Thoroughbred does not win races, prospects
for breeding are limited, often through gelding. However, Quarter Horses are
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used in a number of disciplines, and if not successful in one, may be sold for use
in another.

Phase II – Economics
Thirty five out of 1,634 of the top performers and leading producers (1985
through 2006) were confirmed carriers (N/Hr). Although many of the elite horses
carry the Hr allele, including 12% of the leading lifetime earning sires and 2% of
the leading lifetime earning dams, the majority of top performers and leading
producers do not. The number of elite carriers (N/Hr) will most likely increase
because additional horses will be DNA analyzed which test positive for the Hr
allele.

When elite carriers (N/Hr) are bred, more top money earners are

produced, half of which will be carriers.
Annual winnings of carriers (N/Hr) and normal (N/N) horses indicate that
carrier (N/Hr) winnings ($4,575) increased at a rate of twice that of normal (N/N)
horses ($2,112) per year. Annual earnings of carrier (N/Hr) and normal (N/N)
sires indicated that carrier (N/Hr) sires earnings increased an average of
$63,207, which is also more than twice the rate of normal (N/N) sires ($24,525)
per year. Averaged annual lifetime earnings (LTE) of the top 100 leading sires
indicate that carrier (N/Hr) sires earned significantly more money than normal
(N/N) sires on average per year, however, the increase was slightly less per
year than that of normal (N/N) sires. Earnings of carrier (N/Hr) sires relative to
the total earnings of all sires increased by an average of one-half percent
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annually and, by 2006, 12% of the top 100 lifetime earning sires, which were
DNA confirmed carriers (N/Hr), earned almost 23% of the money.
These increases in annual trends are attributed to the significantly higher
(P ≤ 0.05) average number of earning offspring produced by carrier (N/Hr) sires
(30%) compared to the average number of earning offspring produced by normal
(N/N) sires (25%).

The average numbers of performing and total offspring

produced by carrier (N/Hr) sires were also greater than the averages for normal
(N/N) sires, although not statistically different.

These findings indicate that

numbers of carriers (N/Hr) are increasing, which is further evidence of the
increase in affected (Hr/Hr) horses that are being reported, despite the fact the
allele has been present since 1944 due to Poco Bueno.
Average offspring earnings between carrier (N/Hr) sires and normal (N/N)
sires in either the leading 100 lifetime earning sires or the top five sires for 2001
through 2005 were not statistically different. This is also an indication that the
number of earning offspring is a greater factor in annual dollar increases than the
average amount of earnings won by offspring.
Finally, there was no correlation between inbreeding coefficients and
average offspring earnings of normal (N/N) sires. Although, a positive correlation
was initially observed for carrier (N/Hr) sires (n=5), when the one outlier carrier
(N/Hr), a pre-eminent sire, was removed (n=4), average offspring earnings
actually decreased as inbreeding increased, indicating that there actually may be
no economic advantages to be gained by inbreeding in the cutting horse industry.
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Conclusion
Heritability is the measure of consistency and reliability of the
relationship between performance (phenotypic values) and breeding values
(genotypic values) for a particular trait within a population. On average, when
heritability is high (> 0.04), performance will be a good indicator of breeding
value. Heritability of the Hr gene was estimated to be 0.38 (Tryon et al., 2005),
between 0.2 and 0.4, which generally is considered moderate, although closer
to the higher end of moderate. In contrast, cutting ability has a heritability of
0.12, or less than 0.2, which is considered a low heritable trait (Bourdon, 2000).
When a trait is not very heritable, as with cutting ability, performance records of
parents are not good predictors for progeny performance, which will be
determined more by other factors, such as environment or training.
Linebreeding can increase homozygosity of desired traits of outstanding
performance horses, as most likely the case with both normal (N/N) and carrier
(N/Hr) Quarter Horses. However, it also can express negative traits, as the
case with affected (Hr/Hr) Quarter Horses. Within the general Quarter Horse
population, the Hr allele frequency is 0.02. However, cutting horses have a
significantly higher allele frequency of 0.14, indicating that the disease is much
more prevalent within cutting horse industry (Bannasch, 2008). DNA analysis
is required to identify the difference between a phenotypically and genotypically
normal (N/N) horse, and a phenotypically “normal” (N/Hr) horse that
genotypically carries the recessive gene. However, the carrier (N/Hr) horse will
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transmit the undesirable gene to half of its progeny or foals, thus perpetuating
the transmission of the disease.
Genetic protocols provide the means to increase the incidence of this
disease through super ovulation, artificial insemination, and embryo transfer.
One stallion may breed as many as 200 mares in one season, which could
amount to the production of several thousand foals in his lifetime, and mares can
potentially produce three or even four viable embryos within the same year.
These techniques are altering the gene frequencies over time, as owners and
breeders seek out the top performing horses and leading offspring producers for
breeding choices.
Stud fees on some of these leading sires are in excess of $20,000 and
embryo transfer fees may exceed $3,500. Thousands of dollars are invested in a
foal before parturition. When the disease goes unrecognized until the colt or filly
enters training, at two or more years of age, substantial dollars may have been
expended. When a carrier (N/Hr) is bred to another carrier (N/Hr), the breeder or
owner is at risk of losing 100% of this investment, 25% of the time when an
affected (Hr/Hr) foal is produced. This loss can be prevented by a DNA test,
which is a highly reliable but relatively inexpensive tool. The DNA analysis will
confirm the absence of a carrier (N/Hr) to carrier (N/Hr) mating, and eliminate the
possibility of producing an affected (Hr/Hr) offspring.
Additionally, an affected horse is more likely to be euthanized at a young
age, because of high maintenance for wound management and lack of
productivity potential due to breeding concerns.
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The American Quarter Horse Association (AQHA) ultimately decides the
outcome of animals with genetic defects within the United States registry, as in
the cases of HYPP, parrot mouth, and cryptorchidism. However, the Australian
Quarter Horse Association has already implemented requirements for HERDA
testing in Australia. As of January 1, 2008, all new Foundation Stock recording
applications will require HERDA testing on top of the already required DNA,
OLWS, and HYPP testing. A negative test must be achieved before they will
be accepted into the Foundation.

Additionally, all stallions registered in

Australia as approved breeding sires will be required to have their HERDA
status on record with the Association and printed on their Certificate of
Registration. (Appendix C).
In addition to the financial concerns and registration requirements facing
breeders and owners, there are ethical questions regarding an owner’s
obligation to disclose carrier (N/Hr) status, as well as an owner’s legal recourse
if the resulting foal is affected (Hr/Hr) with the disease (Appendix D). These
issues will be resolved by the horse market or in the court. However, DNA
analysis and appropriate breeding selections can prevent the production of
affected horses that suffer from this disease, reduce economic losses incurred
by owners and breeders, and moderate the perpetuation of the disease within
the Quarter Horse population.

As with any recessive trait, in any species,

removing the carrier state from the population is difficult.
The results of this epidemiologic and economic survey of HC emphasize
the importance of DNA testing, particularly when pedigree evaluations indicate
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Poco Bueno bloodlines. According to AQHA, 1.7 million Quarter Horses trace
back to the great sire, Poco Bueno. Thus, pedigree evaluations will continue to
provide insight as to the horse’s lineage and can be an effective screening tool in
determining whether to utilize a DNA test. Additional information would also be
gained by the evaluation of sale price of carrier (N/Hr) offspring compared to
normal (N/N) offspring.
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Table A.1.

Summary List of Economic Data and Number of Horses Included in
Each Year

Annual Earnings
QHN

QHN

Lifetime Earnings
QHN

QHN

SR

YEAR

TOP
HORSES/
All Ages/All
Date of
Divisions
Publication ANNUAL

1985

14-Mar-86

1-25

1986

27-Feb-87

1-25

1987

26-Feb-88

1-25

1988

24-Feb-89

1-100

1-25

1989

9-Mar-90

1-100

1-30

1990

8-Mar-91

1-100

1991

13-Mar-92

1-100

1-30

1-100

1-40

1992

12-Mar-93

1-100

1-30

1-100

1-30

1993

11-Mar-94

1-100

1-30

1-100

1-25

1994

10-Mar-95

1-100

1-30

1-100

1-25

1995

8-Mar-96

1-100

1-30

1996

14-Mar-97

1-100

1-30

1-100

1-30

1997

13-Mar-98

1-100

1-30

1-100

1-30

1998

15-Mar-99

1-100

1-30

1-100

1999

15-Mar-00

1-100

1-30

1-100

2000

15-Mar-01

1-100

1-30

1-100

2001

15-Mar-02

1-100

1-30

1-100

2002

15-Mar-03

1-100

1-30

1-100

2003

15-Mar-04

1-100

1-30

1-100

2004

15-Mar-05

1-100

1-30

1-100

2005

15-Mar-06

1-100

1-30

1-100

2006

15-Mar-07

1-100

1-30

1-100

EADUNG
LTE
LTE
SIRES/All
LTE
Ages/All HORSES/ SIRES/All SIRES/All
Divisions All Ages/All Ages/All Ages/All
ANNUAL Divisions Divisions Divisions

1-100

50

Table A.1 (continued)
Annual Earnings

QHN

YEAR
5-YEAR
SIRES/ All
Ages/All
Divisions
2001 - 2005

Date of
Publication

QHN

TOP
HORSES/All
Ages/All
Divisions
ANNUAL

Lifetime Earnings

QHN

QHN

L EADUNG
LTE
LTE
SIRES/All
HORSES/ SIRES/All
Ages/All
Divisions All Ages/All Ages/All
Divisions Divisions
ANNUAL

15-Jan-07

1-250

15-Feb-07

1-100

1-Jul-07

1-100

LTE DAMS/
All Ages/All
Divisions

LTE SIRES/
All Ages/All
Divissions

Top Horses/
All Ages/All
Divisions
Money won
thru 2006

1-100

1-Jul-07
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SR
LTE
SIRES/All
Ages/All
Divisions
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Phase I – Epidemiology
Identification of Carrier (N/Hr) and Affected (Hr/Hr) Individuals
Table 4.1 Horses Identified in Phase I by Sex and Status
• 800 Carriers, 45% female 53% male
Table 4.2 Summary of Performance Records from 1985 – 2006
indicating Horses identified as Carriers (N/Hr) vs. Normal (N/N) Horses
• 98% are Normal, including 92% of top 250, 98% of top dams,
88% of top LTE sires
Comparison of Inbreeding Coefficients to Zero (Non-Inbred)
Table 4.3 Mean Inbreeding Coefficients for Each Group of Horses
• Affected and Thoroughbreds were inbred
• Carriers tended towards inbreeding
• Normal were not inbred
Comparison of Inbreeding Coefficients among Groups
Figure 4.1 Comparisons of Mean Inbreeding Coefficients of Four Groups
of Horses
Table 4.4 ANOVA Model and Comparison of Mean Inbreeding Coefficients
among Groups
• Affected and Carriers were not different from each other
• Carriers, Normals, and Thoroughbreds were not different from
each other
• Only Affected were different than Normals and Thoroughbreds
• Affected had highest inbreeding coefficient; Normals had
lowest inbreeding coefficient
Phase II - Economics
Annual Trends – Annual Winnings for Horses
Figure 4.2 Mean Annual Winnings for Carrier (N/Hr) and Normal (N/N)
Horses
Table 4.5 ANOVA GLM Procedure Model only
• Carrier winnings are increasing twice as fast as Normals
• With more Carriers winning, so more are bred, producing 50%
more Carriers that are winning
• As of 2001 Carriers were winning more than Normals
Annual Trends – Annual Earnings for Sires
Figure 4.3 Mean Annual Earnings for Carrier (N/Hr) and Normal (N/N)
Sires
Table 4.6 ANOVA GLM Procedure Model only
• Carriers earn more than Normals (as early as 1991, when these
data were first reported)
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•

Carrier earnings increase at a more rapid rate than Normals by
61%
Annual Trends – Lifetime Earnings for Sires
Figure 4.4 Mean Lifetime Earnings of offspring per sire for leading LTE
Carrier (N/Hr) and Normal (N/N) Horses
Table 4.7 ANOVA GLM Procedure Model only
• Carriers earn more than Normals (1998-2006)
• Carrier rate of increase is slightly less than Normals
Figure 4.5 Percentage of Carrier (N/Hr) Lifetime Earning Sires to Top 100
Lifetime Earning Sires per Year
• Earnings of Carriers increase by ½% every year
• 23% of earnings attributed to 12% of sires
Numbers of Offspring - Lifetime Earning Sires
Table 4.8 Comparison of Leading 100 Lifetime Earning Carrier (N/Hr) and
Normal (N/N) Offspring Information including Average Earnings per
Offspring and Numbers of Offspring (2006)
• Greater average percentage of earning offspring produced by
Carriers compared to Normal sires
• True for average percentage of performing offspring
Figure 4.6Comparisons of Number of Earning, Performing, and Total
Offspring of Carrier and Normal Sires as of 2006
• Average numbers of earning, performing, and total offspring
are greater for carriers than normals
• The only difference that was statistically significant was
earning offspring
Average Offspring Earnings - Lifetime Earning Sires
Figure 4.7 Comparison of Average offspring earnings of the leading 100
LTE earning carrier and normal sires 2006
• Average offspring earnings were greater for carriers than
normals
Table 4.9 ANOVA Model and Comparison of Average Offspring Earnings
of the Leading 100 Lifetime Earning Carrier (N/Hr) Sires and Normal (N/N)
Sires as of 2006
• Differences were not statistically significant
Average Offspring Earnings - Top 250 Five-Year Sires
Figure 4.8 Comparison of average offspring earnings of the top five-year
Carrier (N/Hr) sires and Normal (N/N) sires from 2001 through 2005
• Average offspring earnings were less for carriers than
normals
Table 4.10 ANOVA Model and Comparison of average offspring earnings
of the top five-year Carrier (N/Hr) sires and Normal (N/N) sires from 2001
through 2005
• Differences were not statistically significant
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Comparison of Inbreeding Coefficients and Offspring Earnings
Figure 4.9Comparison of Mean Inbreeding Coefficients of leading fiveyear Carrier (N/Hr) and Normal (N/N) sires and Average Offspring
Earnings of leading five-year Carrier (N/Hr) sires and Normal (N/N) sires
• Carrier inbreeding coefficient were higher than Normals
• Average offspring earnings were greater for Normals
compared to Carriers
• The differences in inbreeding coefficient and earnings were
not statistically significant
Figure 4.10Linear Regression of Top Five Carriers (N/Hr) and Top Five
Normal (N/N) Leading Five-Year Sires Inbreeding Coefficients vs. Average
Offspring Earnings
•No correlation between inbreeding coefficients and average
offspring earnings for normals (n=5)
•Carrier (n=5) average offspring earnings increase as
inbreeding coefficients increase
Figure 4.11Linear Regression of Top Four Carriers (N/Hr) (without outlier)
and Top Five Normal (N/N) Leading Five-Year Sires Inbreeding
Coefficients vs. Average Offspring Earnings
• Outlier in carriers is removed (n=4) and average offspring
earnings decrease as inbreeding coefficients increase
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Registry Services Update - HERDA
22 January 2008
Anna Stevenson
AQHA have been successfully facilitating the HERDA testing procedure
through Cornell University in the USA for the last 2 months. We have received a
wonderful response from members, who have been ordering HERDA testing kits
through our office for the special discounted price of $55 which AQHA negotiated
with Cornell for our members. The most encouraging thing has been members
ordering kits for their breeding mares, even though AQHA have not requested it
at this time. This shows us that members are keen to support our steps to
control the progression of HERDA and ultimately eradicate this crippling disease
in Australia.
AQHA have implemented the new requirements for HERDA testing, which
have come into effect since 1 January 2008. We hope that members will
continue their support by adhering to the below requirements. It is important to
note that horses already registered with AQHA that test positive (N/Hr or Hr/Hr)
to this disease will not be de-registered. At this point all new registrations coming
through for horses born in Australia that test positive (N/Hr or Hr/Hr) will be
accepted for registration. Only imported horses testing positive (N/Hr or Hr/Hr)
will be affected by the new HERDA requirements for 2008. Please see points
below.
1.Effective 1 September 2007, any horses purchased or embryos
harvested overseas prior to 31 December 2007 will be accepted for Registration
with the Association but will require HERDA testing not later than 31 March 2008
and have the result marked on their Certificate of Registration.
2.Effective 1 January 2008, any horses purchased or embryos harvested
overseas after 31 December 2007 must be tested for HERDA by 31 March
2008. Any horse testing positive to HERDA (N/Hr or Hr/Hr) will not be eligible for
AQHA registration.
3.Effective 1 January 2008, AQHA will only accept the results of HERDA
testing facilitated by AQHA through Cornell University. Results received from
testing done by members direct through Davis, Cornell or any other testing
facility will no longer be accepted. If you would like to test your horse for HERDA
and have the results accepted by AQH A, you must have been issued an AQHA
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HERDA testing kit. These are available for $55 through the office.
4.Effective 1 January 2008 all stallions registered with AQHA as approved
breeding sires (IBF endorsed or AQHA classified) will be required to have their
HERDA status on record with the Association and printed on their Certificate of
Registration by 31 July 2008. Any breeding sire without HERDA testing having
been completed by this date may have Stallions Returns held or have their
registration suspended form 1 August 2008 until testing has been carried out.
AQHA is in the process of putting HERDA results up on the online stud book for
all Classified or IBF approved breeding sires. Results for colts, fillies, geldings or
breeding mares will not be advertised at this point, however members can chose
to have the result printed on their horses Certificate of Registration if they wish.
5.Effective 1 January 2008 all new colts and stallions going through the
IBF process will be required to have HERDA testing done before they will be
accepted as a breeding sire with the Association.
6.Effective 1 January 2008 all new Foundation Stock recording
applications will require HERDA testing on top of the already required DNA,
OLWS and HYPP testing. A negative test must be achieved before they will be
accepted into the Foundation recording system.
Members with breeding mares that have linage to the stallion POCO
BUENO (USA 3044) are encouraged to test for HERDA so they can make
educated decisions when choosing a stallion to send their mares to for the 08/09
season. AQHA would like to stress that this disease is active within all Quarter
Horse disciplines and warn that HERDA testing of all breeding stock with lineage
to POCO BUENO will become mandatory within the next 3 years to help put a
stop to the progression of this debilitating disease in Australia.
If you have any queries in regard to the new regulations or would like to
discuss HERDA or our method of testing, please contact the AQHA Registry
Department on (02) 6762 6444.
Please note that AQHA has extended the lodgement date for 07/08
Stallion Returns and Applications for Registrations for foals born during the 07/08
season due to the Equine Influenza outbreak that has affected the entire equine
community.
The lodgement date for Stallion Returns in the 07/08 breeding season has
been extended to:
Mares served between 1 August 2007 and 28 February 2008 – lodge paperwork
by 30 June 2008.
Mares served between 1 March 2008 and 31 July 2008 – lodge paperwork by 31
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October 2008, as normal.
The lodgement date for Applications for Registration for foals born during
the 07/08 season has been extended to:
Foals born between 1 August 2007 and 28 February 2008 – lodge paperwork by
30 June 2008.
Foals born between 1 March 2008 and 31 July 2008 – lodge paperwork by 31
October 2008, as normal.

Australian Quarter Horse Association
131 Gunnedah Road (PO Box 979)
Tamworth, NSW 2340
Phone: (02) 6762 6444 Fax: (02) 6762 6422
ABN: 41 000 964 643
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